Oculis To Participate In Upcoming November Investor Conferences
05 Nov 2025 //
GLOBENEWSWIRE
Oculis Announces Oversubscribed $110 Million Financing
30 Oct 2025 //
GLOBENEWSWIRE
Oculis Showcases Late-Stage Pipeline At Eyecelerator & AAO 2025
14 Oct 2025 //
GLOBENEWSWIRE
Oculis Advances Privosegtor To Registrational In Optic Neuritis
06 Oct 2025 //
GLOBENEWSWIRE
Oculis Presents Phase 2 Acuity Trial Results With Privosegtor
22 Sep 2025 //
GLOBENEWSWIRE
Oculis to Host In-Person and Virtual R&D Day on Business Updates
01 Apr 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support